Health X Platform Limited: AGM Resolutions Passed with Overwhelming Majority
Health X Platform Limited's 37th AGM on September 28, 2026, saw all seven resolutions pass with substantial majority. Key approvals included financial statements, director re-appointments (Mrs. Abha Mittal, Mrs. Anjana Dikshit), borrowing limits, and asset charges. Over 99.99% of votes favoured the resolutions.
The passing of resolutions related to financial statements, director appointments, borrowing limits, and asset charges are routine corporate governance matters that are important for the company's operations but do not represent a significant immediate change in business strategy or financial performance.
All resolutions were passed with a very high majority, indicating strong shareholder support and confidence in the company's management and proposals.
Health X Platform Limited (formerly Sastasundar Ventures Limited) announced that all seven agenda items, including the adoption of audited financial statements for the year ended March 31, 2026, the re-appointment of directors, and approvals for borrowing limits and asset charges, were passed with the requisite majority at its 37th Annual General Meeting (AGM) held on September 28, 2026. The meeting was conducted via Video Conferencing (VC) or Other Audio Visual Means (OAVM).
Voting results indicate strong support for all resolutions. For the financial statements, the re-appointment of Mrs. Abha Mittal as Director, and the re-appointment of Mrs. Anjana Dikshit as Independent Director for a second term from November 10, 2026, to November 9, 2031, over 99.99% of the votes cast were in favour. Similarly, resolutions concerning borrowing limits, creation of mortgage or charge on assets, authorising loans and investments, and advancing loans or providing guarantees under Sections 180(1)(c), 180(1)(a), 186, and 185 of the Companies Act, 2013 respectively, also received overwhelming positive votes, with approvals exceeding 99.98%.
The company provided remote e-voting facilities to its shareholders, with the voting period commencing on September 25, 2026, and concluding on September 27, 2026. A total of 116 members cast their votes through remote e-voting, and all votes were found to be valid. The results have been hosted on the company's website and that of its Registrar and Share Transfer Agent, MUFG Intime India Private Limited.
What to do with a filing like this
Health X Platform Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Health X Platform Limited. Read the original for the full detail.